Christopher C. Bond
AuthID: R-00G-SVW
1
TÃTULO: Impact of seizure frequency reduction on health-related quality of life among clinical trial subjects with refractory partial-onset seizures: A pooled analysis of phase III clinical trials of eslicarbazepine acetate Full Text
AUTORES: Fulton F Velez; Christopher C Bond; Kathryn P Anastassopoulos; Xuezhe Z Wang; Rui Sousa; David Blum; Joyce A Cramer;
PUBLICAÇÃO: 2017, FONTE: EPILEPSY & BEHAVIOR, VOLUME: 68
AUTORES: Fulton F Velez; Christopher C Bond; Kathryn P Anastassopoulos; Xuezhe Z Wang; Rui Sousa; David Blum; Joyce A Cramer;
PUBLICAÇÃO: 2017, FONTE: EPILEPSY & BEHAVIOR, VOLUME: 68
INDEXADO EM: 
WOS
WOS2
TÃTULO: Severity and burden of partial-onset seizures in a phase III trial of eslicarbazepine acetate Full Text
AUTORES: Joyce A Cramer; Fulton F Velez; Kathryn P Anastassopoulos; Christopher C Bond; Frank G Gilliam; Philippe Ryvlin; Luigi M Specchio; Xuezhe Z Wang; David Blum; Joana Moreira; Francisco Rocha;
PUBLICAÇÃO: 2015, FONTE: EPILEPSY & BEHAVIOR, VOLUME: 53
AUTORES: Joyce A Cramer; Fulton F Velez; Kathryn P Anastassopoulos; Christopher C Bond; Frank G Gilliam; Philippe Ryvlin; Luigi M Specchio; Xuezhe Z Wang; David Blum; Joana Moreira; Francisco Rocha;
PUBLICAÇÃO: 2015, FONTE: EPILEPSY & BEHAVIOR, VOLUME: 53
